Sureda A / 2008 / Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation / J Clin Oncol 26:455~462 Sureda A / 2009 / Allogeneic stem cell transplantation after reduced intensity conditioning (RIC-allo) in patients with relapsed or refractory Hodgkin's lymphoma (HL): final analysis of the HDR-allo protocol- A prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea (GEL/TAMO) and the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation [Abstract] / Blood 114:A658 Forero-Torres A / 2009 / A phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma / Br J Haematol 146:171~179 Fanale M / 2008 / Phase I study of bortezomib in combination with ICE (BICE) in patients with relapsed/refractory classical Hodgkin lymphoma [Abstract] / Blood 112:A3048 Georgakis GV / 2006 / Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma / Br J Haematol 132:503~511